GANO KYLE (Chief Business Development Off) exercised options at NEUROCRINE BIOSCIENCES INC
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/3/2026ACC: 0001567160-26-000005
Officer· Chief Business Development Off
Since Aug 2018
-1.58K
Net shares
Net seller
$215.0K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
2.93K acquired · 4.51K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.93K
Price / share
—
Trade value
—
% of position
2.1%
1/31/2026
140.41K→143.33K
Common Stock
Direct
Shares
−1.58K
Price / share
$136.06
Trade value
$214.97K
% of position
1.1%
1/31/2026
143.33K→141.75K
Total
Net shares
+1.35K
Net value
-$214.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2026 | M · Option Exercise | +2.93K | — | — | 2.1% | 140.41K | 143.33K |
| Common Stock Direct | 1/31/2026 | F · Tax Withholding | −1.58K | $136.06 | $214.97K | 1.1% | 143.33K | 141.75K |
| Total | +1.35K | -$214.97K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
2.93K shares
Shares
−2.93K
Strike price
Held after
0.00
Exercisable
—
1/31/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock2.93K shares | 1/31/2026 | M · Option Exercise | −2.93K | — | 0.00 |